Impaired degradation of phytanic acid in cells from patients with mitochondriopathies: evidence for the involvement of ETF and the respiratory chain in phytanic acid alpha-oxidation.

Abstract	Phytanic acid alpha-oxidation was studied in cultures of skin fibroblasts and myoblasts from patients with various defects of the respiratory chain in order to obtain information on the subcellular site and the mechanism of this pathway. In fibroblasts from patients with complex IV (cytochrome c oxidase) deficiency or glutaricaciduria type II, phytanic acid alpha-oxidation was reduced to 14% of normal, whereas in myoblasts from patients with complex I (NADH-Q reductase) deficiency, it was normal. Apparently, at least one step of phytanic acid alpha-oxidation occurs in mitochondria and in this process electrons are transferred to the respiratory chain via the electron-transfer flavoprotein (ETF).
Authors	R Fingerhut, W Schmitz, B Garavaglia, H Reichmann, E Conzelmann
Journal	Journal of inherited metabolic disease (J Inherit Metab Dis) Vol. 17 Issue 5 Pg. 527-32 ( 1994) ISSN: 0141-8955 [Print] United States
PMID	7837758 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Electron-Transferring Flavoproteins Flavoproteins Phytanic Acid NADH Dehydrogenase
Topics	Cells, Cultured Cytochrome-c Oxidase Deficiency Electron Transport Electron-Transferring Flavoproteins Female Flavoproteins (physiology) Humans Infant Infant, Newborn Male Mitochondria (metabolism) NADH Dehydrogenase (deficiency) Oxidation-Reduction Phytanic Acid (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!